Fibrates and high-dose statins to prevent coronary heart disease events

被引：1
|
作者：
Jones P.H. [1 ]
机构：
[1] Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston
来源：
Current Cardiology Reports | 1999年 / 1卷 / 3期
关键词：
Atorvastatin; Bezafibrate; Coronary Heart Disease Event; Postprandial Lipemia; Bezafibrate Infarction Prevention;
D O I：
10.1007/s11886-999-0026-8
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：223 / 224
页数：1
相关论文
共 50 条
  • [41] Temporal Trends in the Use of High-Dose Potent Statins following Acute Coronary Syndrome in Israel
    Elis, Avishay
    Pereg, David
    Dicker, Dror
    Gevrielov-Yusim, Natalie
    Goldenberg, Ilan
    Matetzky, Shlomi
    Kopel, Eran
    Klempfner, Robert
    CARDIOLOGY, 2014, 128 (03) : 266 - 272
  • [42] HIGH-DOSE DIPYRIDAMOLE ECHOCARDIOGRAPHY TEST IN CORONARY-ARTERY DISEASE AFTER HEART-TRANSPLANTATION
    CILIBERTO, GR
    MASSA, D
    MANGIAVACCHI, M
    DANZI, GB
    PIRELLI, S
    FALETRA, F
    FRIGERIO, M
    GRONDA, E
    DEVITA, C
    EUROPEAN HEART JOURNAL, 1993, 14 (01) : 48 - 52
  • [43] Control of lipoprotein levels in coronary heart disease today: A focus on high-dose fluvastatin and combination therapies
    Leitersdorf, E
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 567 - 570
  • [44] THE ROLE OF STATINS IN PREVENTION OF ACUTE CORONARY EVENTS IN PATIENTS WITH CORONARY HEART DISEASE BEFORE AND AFTER CORONARY ANGIOPLASTY AND STENTING
    Petelina, T.
    Musikhina, N.
    Gapon, L.
    Sharoyan, U.
    ATHEROSCLEROSIS, 2018, 275 : E223 - E223
  • [45] Comparative Benefits of Statins in Coronary Heart Disease
    Ermakova, Viktoriya
    Bataev, Hizir
    Semenenko, Natalya
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2021, 12 (01) : 7 - 13
  • [46] Aggressive cholesterol reduction with high-dose statins improves prognosis in peripheral arterial disease
    Feringa, Harm H.
    Dunkelgrun, Martin
    Hoeks, Sanne
    van Domburg, Ron
    Vidakovic, Radosav
    Karagiannis, Stefanos
    Azizi, Fahim
    Welten, Gijs
    Lameris, Thomas
    Schouten, Olaf
    Poldermans, Don
    CIRCULATION, 2006, 114 (18) : 112 - 112
  • [47] Cost effectiveness of statins in coronary heart disease
    Franco, OH
    Peeters, A
    Looman, CWN
    Bonneux, L
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2005, 59 (11) : 927 - 933
  • [48] Statins for the Primary Prevention of Coronary Heart Disease
    Li, Min
    Wang, Xiaoli
    Li, Xinyi
    Chen, Heqing
    Hu, Yeyin
    Zhang, Xiatian
    Tang, Xiaoyi
    Miao, Yaodong
    Tian, Guihua
    Shang, Hongcai
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [49] Statins, cholesterol, and the prevention of coronary heart disease
    Freeman, Mason W.
    FASEB JOURNAL, 2006, 20 (02): : 200 - 201
  • [50] Candidate Mechanisms for Regression of Coronary Atherosclerosis with High-Dose Statins Insight from Intravascular Ultrasonography Trials
    Sipahi, Ilke
    Tuzcu, E. Murat
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (06) : 365 - 371
12345